Solid Biosciences

Solid Biosciences

  • Founded: 2013
  • Location: Cambridge, MA
  • Employee range: 50 - 200
  • Clinical stage: Clin0
  • Therapy area: DMD
  • Drug types: GEN, MUS, NEU, CVV, RAR
  • Lead product: SGT-003
  • Product link:
  • Funding: $144M stock Mar 2021; $90M stock (PP) Dec 2020; $60M stock (PP) Jul 2019; $134M IPO Jan 2018

job board

Short description:

Gene Therapy, Devices, Biologics, Small Molecules all for DMD

Drug notes:

ABV-202 Clin0 Friedreich's ataxia; AVB-401 Clin0 dilated cardiomyopathy; undisclosed Clin0 cardiac condition

Long description:

Contact us to add description:


Solid Biosciences
Scientist- Cardiac Disease
Greater Boston|92 days ago

© 2024 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy